The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Human Coronaviruses: Insights into Environmental Resistance and Its Influence on the Development of New Antiseptic Strategies
Open accessAbstract
The Coronaviridae family, an enveloped RNA virus family, and, more particularly, human coronaviruses (HCoV), were historically known to be responsible for a large portion of common colds and other upper respiratory tract infections. HCoV are now known to be involved in more serious respiratory diseases, i.e. bronchitis, bronchiolitis or pneumonia, especially in young children and neonates, elderly people and immunosuppressed patients. They have also been involved in nosocomial viral infections. In 2002–2003, the outbreak of severe acute respiratory syndrome (SARS), due to a newly discovered coronavirus, the SARS-associated coronavirus (SARS-CoV); led to a new awareness of the medical importance of the Coronaviridae family. This pathogen, responsible for an emerging disease in humans, with high risk of fatal outcome; underline the pressing need for new approaches to the management of the infection, and primarily to its prevention. Another interesting feature of coronaviruses is their potential environmental resistance, despite the accepted fragility of enveloped viruses. Indeed, several studies have described the ability of HCoVs (i.e. HCoV 229E, HCoV OC43 (also known as betacoronavirus 1), NL63, HKU1 or SARS-CoV) to survive in different environmental conditions (e.g. temperature and humidity), on different supports found in hospital settings such as aluminum, sterile sponges or latex surgical gloves or in biological fluids. Finally, taking into account the persisting lack of specific antiviral treatments (there is, in fact, no specific treatment available to fight coronaviruses infections), the Coronaviridae specificities (i.e. pathogenicity, potential environmental resistance) make them a challenging model for the development of efficient means of prevention, as an adapted antisepsis-disinfection, to prevent the environmental spread of such infective agents. This review will summarize current knowledge on the capacity of human coronaviruses to survive in the environment and the efficacy of well-known antiseptic-disinfectants against them, with particular focus on the development of new methodologies to evaluate the activity of new antiseptic-disinfectants on viruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,344
Coronavirus as a possible cause of severe acute respiratory syndrome
Peiris, J., Lai, S., Poon, L., Guan, Y., Yam, L., Lim, W., Nicholls, J., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,915
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
Lee, N., Hui, D., Wu, A., Chan, P., Cameron, P., Joynt, G. M., Ahuja, A., Yung, M. Y., Leung, C. B., To, K. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030685 · Cited by 2,628
Bats Are Natural Reservoirs of SARS-Like Coronaviruses
Li, W., Shi, Z., Yu, M., Ren, W., Smith, C., Epstein, J. H., Wang, H., Crameri, G., Hu, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,560
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375
Identification of a new human coronavirus
van der Hoek, L., Pyrc, K., Jebbink, M. F., Vermeulen-Oost, W., Berkhout, R. J. M., Wolthers, K. C., Wertheim-van Dillen, P. M. E., Kaandorp, J., Spaargaren, J., & Berkhout, B. (2004) · Nature Medicine · doi:10.1038/nm1024 · Cited by 1,886
Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats
Lau, S. K. P., Woo, P. C. Y., Li, K. S. M., Huang, Y., Tsoi, H.-W., Wong, B. H. L., Wong, S. S. Y., Leung, S.-Y., Chan, K.-H., & Yuen, K.-Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506735102 · Cited by 1,544
Woo, P. C. Y., Lau, S. K. P., Chu, C.-M., Chan, K.-H., Tsoi, H.-W., Huang, Y., Wong, B. H. L., Poon, R. W. S., Cai, J. J., Luk, W.-K., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.884-895.2005 · Cited by 1,525
Transmission Dynamics and Control of Severe Acute Respiratory Syndrome
Lipsitch, M., Cohen, T., Cooper, B., Robins, J. M., Ma, S., James, L., Gopalakrishna, G., Chew, S. K., Tan, C. C., Samore, M. H., et al. (2003) · Science · doi:10.1126/science.1086616 · Cited by 1,485
Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area
Booth, C. M. (2003) · JAMA · doi:10.1001/jama.289.21.joc30885 · Cited by 1,406
The Severe Acute Respiratory Syndrome
Peiris, J. S. M., Yuen, K. Y., Osterhaus, A. D. M. E., & Stöhr, K. (2003) · New England Journal of Medicine · doi:10.1056/nejmra032498 · Cited by 1,346
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus
Cinatl, J., Morgenstern, B., Bauer, G., Chandra, P., Rabenau, H., & Doerr, H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13615-x · Cited by 1,158
Riley, S., Fraser, C., Donnelly, C. A., Ghani, A. C., Abu-Raddad, L. J., Hedley, A. J., Leung, G. M., Ho, L.-M., Lam, T.-H., Thach, T. Q., et al. (2003) · Science · doi:10.1126/science.1086478 · Cited by 1,150
Identification of Severe Acute Respiratory Syndrome in Canada
Poutanen, S. M., Low, D. E., Henry, B., Finkelstein, S., Rose, D., Green, K., Tellier, R., Draker, R., Adachi, D., Ayers, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030634 · Cited by 1,132
Donnelly, C. A., Ghani, A. C., Leung, G. M., Hedley, A. J., Fraser, C., Riley, S., Abu-Raddad, L. J., Ho, L.-M., Thach, T.-Q., Chau, P., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13410-1 · Cited by 940 · cited 1×
“Moreover, the mortality rate was higher than 50% in aged (>60-year-old) populations [55] [56] [57] .”
BackgroundA New Virus Isolated from the Human Respiratory Tract.
Hamre, D., & Procknow, J. J. (1966) · Experimental Biology and Medicine · doi:10.3181/00379727-121-30734 · Cited by 884
Seto, W., Tsang, D., Yung, R., Ching, T., Ng, T., Ho, M., Ho, L., & Peiris, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13168-6 · Cited by 863
Transmission of the Severe Acute Respiratory Syndrome on Aircraft
Olsen, S. J., Chang, H.-L., Cheung, T. Y.-Y., Tang, A. F.-Y., Fisk, T. L., Ooi, S. P.-L., Kuo, H.-W., Jiang, D. D.-S., Chen, K.-T., Lando, J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa031349 · Cited by 719
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
Yang, Z.-Y., Kong, W.-P., Huang, Y., Roberts, A., Murphy, B. R., Subbarao, K., & Nabel, G. J. (2004) · Nature · doi:10.1038/nature02463 · Cited by 665
A previously undescribed coronavirus associated with respiratory disease in humans
Fouchier, R. A. M., Hartwig, N. G., Bestebroer, T. M., Niemeyer, B., de Jong, J. C., Simon, J. H., & Osterhaus, A. D. M. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400762101 · Cited by 598
Vijgen, L., Keyaerts, E., Moës, E., Thoelen, I., Wollants, E., Lemey, P., Vandamme, A.-M., & Van Ranst, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1595-1604.2005 · Cited by 594
Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease.
McIntosh, K., Dees, J. H., Becker, W. B., Kapikian, A. Z., & Chanock, R. M. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.57.4.933 · Cited by 581
Tseng, C.-T., Sbrana, E., Iwata-Yoshikawa, N., Newman, P. C., Garron, T., Atmar, R. L., Peters, C. J., & Couch, R. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035421 · Cited by 561
Stability and inactivation of SARS coronavirus
Rabenau, H. F., Cinatl, J., Morgenstern, B., Bauer, G., Preiser, W., & Doerr, H. W. (2005) · Medical Microbiology and Immunology · doi:10.1007/s00430-004-0219-0 · Cited by 558
Neuroinvasion by Human Respiratory Coronaviruses
Arbour, N., Day, R., Newcombe, J., & Talbot, P. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.8913-8921.2000 · Cited by 522
Immunopathogenesis of coronavirus infections: implications for SARS
Dandekar, A. A., & Perlman, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1732 · Cited by 499
Bolles, M., Deming, D., Long, K., Agnihothram, S., Whitmore, A., Ferris, M., Funkhouser, W., Gralinski, L., Totura, A., Heise, M., et al. (2011) · Journal of Virology · doi:10.1128/jvi.06048-11 · Cited by 477 · cited 1×
“Indeed, a similar immunopathologic reaction has been described in mice vaccinated with a SARS-CoV vaccine and subsequently challenged with SARS-CoV [97] [98] [99] [100] [101] .”
BackgroundKariwa, H., Fujii, N., & Takashima, I. (2006) · Dermatology · doi:10.1159/000089211 · Cited by 458
Varia, M., Wilson, S., Sarwal, S., McGeer, A., Gournis, E., Galanis, E., & Henry, B. (2003) · PubMed · Cited by 426
Bisht, H., Roberts, A., Vogel, L., Bukreyev, A., Collins, P. L., Murphy, B. R., Subbarao, K., & Moss, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401939101 · Cited by 420
Shu-Mingduan, Xin-Shengzhao, Rui-Fuwen, Jing-Jinghuang, Guo-Huapi, Su-XIANGZHANG, Junhan, Bi, S., Liruan, Xiao-Pingdong, et al. (2003) · 生物医学与环境科学:英文版 · Cited by 419
Zhao, Z. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05320-0 · Cited by 407
Survival of surrogate coronaviruses in water
Casanova, L., Rutala, W. A., Weber, D. J., & Sobsey, M. D. (2009) · Water Research · doi:10.1016/j.watres.2009.02.002 · Cited by 405
Identification of a Novel Coronavirus in Bats
Poon, L. L. M., Chu, D. K. W., Chan, K. H., Wong, O. K., Ellis, T. M., Leung, Y. H. C., Lau, S. K. P., Woo, P. C. Y., Suen, K. Y., Yuen, K. Y., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2001-2009.2005 · Cited by 397
Duan, S., Zhao, X.-S., Wen, R.-F., Huang, J.-J., Guohua, P., Su-xiang, Z., Han, J., Bi, S., Ruan, L., & Dong, X. (2003) · PubMed · Cited by 383
Nicholson, K. G., Kent, J., Hammersley, V., & Cancio, E. (1997) · BMJ · doi:10.1136/bmj.315.7115.1060 · Cited by 381
Evidence of human coronavirus HKU1 and human bocavirus in Australian children
SLOOTS, T., MCERLEAN, P., SPEICHER, D., ARDEN, K., NISSEN, M., & MACKAY, I. (2006) · Journal of Clinical Virology · doi:10.1016/j.jcv.2005.09.008 · Cited by 360
Kan, B., Wang, M., Jing, H., Xu, H., Jiang, X., Yan, M., Liang, W., Zheng, H., Wan, K., Liu, Q., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.18.11892-11900.2005 · Cited by 346
Chiu, S. S., Hung Chan, K., Wing Chu, K., Kwan, S. W., Guan, Y., Man Poon, L. L., & Peiris, J. S. M. (2005) · Clinical Infectious Diseases · doi:10.1086/430301 · Cited by 325
Molecular diversity of coronaviruses in bats
Woo, P. C. Y., Lau, S. K. P., Li, K. S. M., Poon, R. W. S., Wong, B. H. L., Tsoi, H.-W., Yip, B. C. K., Huang, Y., Chan, K.-H., & Yuen, K.-Y. (2006) · Virology · doi:10.1016/j.virol.2006.02.041 · Cited by 322
Survival of Severe Acute Respiratory Syndrome Coronavirus
Lai, M. Y. Y., Cheng, P. K. C., & Lim, W. W. L. (2005) · Clinical Infectious Diseases · doi:10.1086/433186 · Cited by 313
Croup Is Associated with the Novel Coronavirus NL63
van der Hoek, L., Sure, K., Ihorst, G., Stang, A., Pyrc, K., Jebbink, M. F., Petersen, G., Forster, J., Berkhout, B., & Überla, K. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020240 · Cited by 308
HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus
Yamamoto, N., Yang, R., Yoshinaka, Y., Amari, S., Nakano, T., Cinatl, J., Rabenau, H., Doerr, H. W., Hunsmann, G., Otaka, A., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.083 · Cited by 306
Coronavirus 229E-Related Pneumonia in Immunocompromised Patients
Pene, F., Merlat, A., Vabret, A., Rozenberg, F., Buzyn, A., Dreyfus, F., Cariou, A., Freymuth, F., & Lebon, P. (2003) · Clinical Infectious Diseases · doi:10.1086/377612 · Cited by 303
Effects of a "new" human respiratory virus in volunteers.
Bradburne, A. F., Bynoe, M. L., & Tyrrell, D. A. (1967) · BMJ · doi:10.1136/bmj.3.5568.767 · Cited by 301
Hsu, L.-Y., Lee, C.-C., Green, J. A., Ang, B., Paton, N. I., Lee, L., Villacian, J. S., Lim, P.-L., Earnest, A., & Leo, Y.-S. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0906.030264 · Cited by 283
Deming, D., Sheahan, T., Heise, M., Yount, B., Davis, N., Sims, A., Suthar, M., Harkema, J., Whitmore, A., Pickles, R., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030525 · Cited by 275
Almeida, J. D., & Tyrrell, D. A. J. (1967) · Journal of General Virology · doi:10.1099/0022-1317-1-2-175 · Cited by 273
Efficacy of various disinfectants against SARS coronavirus
Rabenau, H. F., Kampf, G., Cinatl, J., & Doerr, H. W. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2004.12.023 · Cited by 271
Sizun, J., Yu, M. W. N., & Talbot, P. J. (2000) · Journal of Hospital Infection · doi:10.1053/jhin.2000.0795 · Cited by 263
Bukreyev, A., Lamirande, E. W., Buchholz, U. J., Vogel, L. N., Elkins, W. R., Claire, M. S., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16501-x · Cited by 256
Survival Characteristics of Airborne Human Coronavirus 229E
Ijaz, M. K., Brunner, A. H., Sattar, S. A., Nair, R. C., & Johnson-Lussenburg, C. M. (1985) · Journal of General Virology · doi:10.1099/0022-1317-66-12-2743 · Cited by 254
Human Coronavirus NL63, France
Vabret, A., Mourez, T., Dina, J., van der Hoek, L., Gouarin, S., Petitjean, J., Brouard, J., & Freymuth, F. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1108.050110 · Cited by 252
Yasui, F., Kai, C., Kitabatake, M., Inoue, S., Yoneda, M., Yokochi, S., Kase, R., Sekiguchi, S., Morita, K., Hishima, T., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6337 · Cited by 252
An Outbreak of Coronavirus OC43 Respiratory Infection in Normandy, France
Vabret, A., Mourez, T., Gouarin, S., Petitjean, J., & Freymuth, F. (2003) · Clinical Infectious Diseases · doi:10.1086/374222 · Cited by 248
Woo, P. C. Y., Lau, S. K. P., Tsoi, H., Huang, Y., Poon, R. W. S., Chu, C., Lee, R. A., Luk, W., Wong, G. K. M., Wong, B. H. L., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/497151 · Cited by 245
van Elden, L. J. R., van Loon, A. M., van Alphen, F., Hendriksen, K. A. W., Hoepelman, A. I. M., van Kraaij, M. G. J., Oosterheert, J., Schipper, P., Schuurman, R., & Nijhuis, M. (2004) · The Journal of Infectious Diseases · doi:10.1086/381207 · Cited by 225
Esper, F., Weibel, C., Ferguson, D., Landry, M. L., & Kahn, J. S. (2005) · The Journal of Infectious Diseases · doi:10.1086/428138 · Cited by 219
Detection of coronavirus RNA and antigen in multiple sclerosis brain
Murray, R. S., Brown, B., Brain, D., & Cabirac, G. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310511 · Cited by 215
Morgenstern, B., Michaelis, M., Baer, P. C., Doerr, H. W., & Cinatl, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.128 · Cited by 214
Arden, K. E., Nissen, M. D., Sloots, T. P., & Mackay, I. M. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20288 · Cited by 204
Sattar, S. A., Springthorpe, V. S., Karim, Y., & Loro, P. (1989) · Epidemiology and Infection · doi:10.1017/s0950268800030211 · Cited by 198
Detection of the New Human Coronavirus HKU1: A Report of 6 Cases
Vabret, A., Dina, J., Gouarin, S., Petitjean, J., Corbet, S., & Freymuth, F. (2006) · Clinical Infectious Diseases · doi:10.1086/500136 · Cited by 198
Rhinovirus and Coronavirus Infection–Associated Hospitalizations among Older Adults
Falsey, A. R., Walsh, E. E., & Hayden, F. G. (2002) · The Journal of Infectious Diseases · doi:10.1086/339881 · Cited by 194
Severe Acute Respiratory Syndrome Coronavirus on Hospital Surfaces
Dowell, S. F., Simmerman, J. M., Erdman, D. D., Wu, J.-S. J., Chaovavanich, A., Javadi, M., Yang, J.-Y., Anderson, L. J., Tong, S., & Ho, M. S. (2004) · Clinical Infectious Diseases · doi:10.1086/422652 · Cited by 193
Human coronavirus gene expression in the brains of multiple sclerosis patients
Stewart, J. N., Mounir, S., & Talbot, P. J. (1992) · Virology · doi:10.1016/0042-6822(92)90220-j · Cited by 192
A multicentre collaboration to investigate the cause of severe acute respiratory syndrome
Stöhr, K. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13376-4 · Cited by 186
Chen, Z., Zhang, L., Qin, C., Ba, L., Yi, C. E., Zhang, F., Wei, Q., He, T., Yu, W., Yu, J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2678-2688.2005 · Cited by 183
Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
CZUB, M., WEINGARTL, H., CZUB, S., HE, R., & CAO, J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.033 · Cited by 180
Zhang, X. M., Herbst, W., Kousoulas, K. G., & Storz, J. (1994) · Journal of Medical Virology · doi:10.1002/jmv.1890440207 · Cited by 177
Acute and Persistent Infection of Human Neural Cell Lines by Human Coronavirus OC43
Arbour, N., Côté, G., Lachance, C., Tardieu, M., Cashman, N. R., & Talbot, P. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3338-3350.1999 · Cited by 174
Human Coronavirus NL63 Infection in Canada
Bastien, N., Anderson, K., Hart, L., Van Caeseele, P., Brandt, K., Milley, D., Hatchette, T., Weiss, E. C., & Li, Y. (2005) · The Journal of Infectious Diseases · doi:10.1086/426869 · Cited by 173
Gerna, G., Campanini, G., Rovida, F., Percivalle, E., Sarasini, A., Marchi, A., & Baldanti, F. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20645 · Cited by 172
Identification and containment of an outbreak of SARS in a community hospital.
Dwosh, H. A., Hong, H. H. L., Austgarden, D., Herman, S., & Schabas, R. (2003) · Europe PMC (PubMed Central) · Cited by 172
Isolation of rhinoviruses and coronaviruses from 38 colds in adults
Larson, H. E., Reed, S. E., & Tyrrell, D. A. J. (1980) · Journal of Medical Virology · doi:10.1002/jmv.1890050306 · Cited by 168
Human Respiratory Coronavirus OC43: Genetic Stability and Neuroinvasion
St-Jean, J. R., Jacomy, H., Desforges, M., Vabret, A., Freymuth, F., & Talbot, P. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.16.8824-8834.2004 · Cited by 166
Sturman, L. S., Ricard, C. S., & Holmes, K. V. (1990) · Journal of Virology · doi:10.1128/jvi.64.6.3042-3050.1990 · Cited by 161
SARS in Hospital Emergency Room
Chen, Y.-C., Huang, L.-M., Chan, C.-C., Su, C.-P., Chang, S.-C., Chang, Y.-Y., Chen, M.-L., Hung, C.-C., Chen, W.-J., Lin, F.-Y., et al. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1005.030579 · Cited by 159
Kapadia, S. U., Rose, J. K., Lamirande, E. W., Vogel, L., Subbarao, K., & Roberts, A. (2005) · Virology · doi:10.1016/j.virol.2005.06.016 · Cited by 155
See, R. H., Zakhartchouk, A. N., Petric, M., Lawrence, D. J., Mok, C. P. Y., Hogan, R. J., Rowe, T., Zitzow, L. A., Karunakaran, K. P., Hitt, M., et al. (2006) · Journal of General Virology · doi:10.1099/vir.0.81579-0 · Cited by 153
He, Y., Li, J., Heck, S., Lustigman, S., & Jiang, S. (2006) · Journal of Virology · doi:10.1128/jvi.00083-06 · Cited by 135
Persistent Infection of Human Oligodendrocytic and Neuroglial Cell Lines by Human Coronavirus 229E
Arbour, N., Ékandé, S., Côté, G., Lachance, C., Chagnon, F., Tardieu, M., Cashman, N. R., & Talbot, P. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3326-3337.1999 · Cited by 133
He, Y., Zhou, Y., Siddiqui, P., & Jiang, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.052 · Cited by 130
Dellanno, C., Vega, Q. C., & Boesenberg, D. (2009) · American Journal of Infection Control · doi:10.1016/j.ajic.2009.03.012 · Cited by 129
Gagneur, A., Sizun, J., Vallet, S., Legr, M. C., Picard, B., & Talbot, P. J. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1179 · Cited by 122
Spruth, M., Kistner, O., Savidis-Dacho, H., Hitter, E., Crowe, B. A., Gerenčer, M., Brühl, P., Grillberger, L., Reiter, M., Tauer, C., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.08.055 · Cited by 121
Gerna, G., Percivalle, E., Sarasini, A., Campanini, G., Piralla, A., Rovida, F., Genini, E., Marchi, A., & Baldanti, F. (2007) · Journal of Clinical Virology · doi:10.1016/j.jcv.2006.12.008 · Cited by 121
Takasuka, N. (2004) · International Immunology · doi:10.1093/intimm/dxh143 · Cited by 113
Coronavirus infections of man associated with diseases other than the common cold
Riski, H., & Hovi, T. (1980) · Journal of Medical Virology · doi:10.1002/jmv.1890060309 · Cited by 112
Vabret, A., Dina, J., Gouarin, S., Petitjean, J., Tripey, V., Brouard, J., & Freymuth, F. (2007) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2007.01246.x · Cited by 107
Inactivation of surrogate coronaviruses on hard surfaces by health care germicides
Hulkower, R. L., Casanova, L. M., Rutala, W. A., Weber, D. J., & Sobsey, M. D. (2011) · American Journal of Infection Control · doi:10.1016/j.ajic.2010.08.011 · Cited by 106
Effect of pH and temperature on the infectivity of human coronavirus 229E
Lamarre, A., & Talbot, P. J. (1989) · Canadian Journal of Microbiology · doi:10.1139/m89-160 · Cited by 105
Canine coronavirus inactivation with physical and chemical agents
Pratelli, A. (2007) · The Veterinary Journal · doi:10.1016/j.tvjl.2007.03.019 · Cited by 91
Esposito, S., Bosis, S., Niesters, H. G. M., Tremolati, E., Begliatti, E., Rognoni, A., Tagliabue, C., Principi, N., & Osterhaus, A. D. M. E. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20745 · Cited by 91
Infection of primary cultures of human neural cells by human coronaviruses 229E and OC43
Bonavia, A., Arbour, N., Yong, V. W., & Talbot, P. J. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.800-806.1997 · Cited by 90
Zhou, Z., Post, P. L., Chubet, R. G., Holtz, K., McPherson, C. E., Petrić, M., & Cox, M. M. J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.01.059 · Cited by 89
The Pediatric Burden of Human Coronaviruses Evaluated for Twenty Years
Talbot, H. K., Shepherd, B. E., Crowe, J. E., Griffin, M. R., Edwards, K. M., Podsiad, A. B., Tollefson, S. J., Wright, P. F., & Williams, J. V. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31819d0d27 · Cited by 89
Possible role of an animal vector in the SARS outbreak at Amoy Gardens
Ng, S. K. C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14121-9 · Cited by 88
Tang, L., Zhu, Q., Qin, E.-D., Yu, M., Ding, Z., Shi, H., Cheng, X., Wang, C., Chang, G., Zhu, Q., et al. (2004) · DNA and Cell Biology · doi:10.1089/104454904323145272 · Cited by 85
The SARS epidemic in Hong Kong
Lee, S. H. (2003) · Journal of Epidemiology & Community Health · doi:10.1136/jech.57.9.652 · Cited by 78
Lokugamage, K. G., Iwata‐Yoshikawa, N., Ito, N., Watts, D. M., Wyde, P. R., Wang, N., Newman, P. C., Tseng, C.-T. K., Peters, C. J., & Makino, S. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.11.092 · Cited by 73
Immunogenicity of SARS inactivated vaccine in BALB/c mice
Xiong, S., Wang, Y., Zhang, M., Liu, X., Zhang, C., Liu, S., Qian, C.-W., Li, J., Lu, J., Wan, Z.-Y., et al. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.06.014 · Cited by 70
Development of antiviral therapy for severe acute respiratory syndrome
CINATLJR, J., Michaelis, M., Hoever, G., Preiser, W., & Doerr, H. W. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.03.002 · Cited by 70
Coronavirus Pneumonia Following Autologous Bone Marrow Transplantation for Breast Cancer
Folz, R. J., & Elkordy, M. (1999) · CHEST Journal · doi:10.1378/chest.115.3.901 · Cited by 68
Severe Acute Respiratory Syndrome–associated Coronavirus in Lung Tissue
Mazzulli, T., Farcas, G. A., Poutanen, S. M., Willey, B. M., Low, D. E., BUTANY, J. W., Asa, S. L., & Kain, K. C. (2004) · Emerging infectious diseases · doi:10.3201/eid1001.030404 · Cited by 65
Coronaviruses and their therapy
Haagmans, B. L., & Osterhaus, A. D. M. E. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.05.019 · Cited by 58
Woo, P. C. Y., Lau, S. K. P., Tsoi, H.-W., Chen, Z., Wong, B. H. L., Zhang, L., Chan, J. K. H., Wong, L.-P., He, W., Ma, C., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.05.023 · Cited by 56
Wang, Z., Yuan, Z., Matsumoto, M., Hengge, U. R., & Chang, Y.-F. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.147 · Cited by 53
SARS Vaccine Protective in Mice
Stadler, K., Roberts, A., Becker, S., Vogel, L., Eickmann, M., Kolesnikova, L., Klenk, H. D., Murphy, B. R., Rappuoli, R., Abrignani, S., et al. (2005) · Emerging infectious diseases · doi:10.3201/eid1108.041003 · Cited by 47
DNA Vaccine of SARS-Cov S Gene Induces Antibody Response in Mice
Zhao, P., Ke, J.-S., Qin, Z.-L., Ren, H., Zhao, L.-J., Yu, J.-G., Gao, J., Zhu, S.-Y., & Qi, Z.-T. (2004) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/36.1.37 · Cited by 37
Cinatl, J. J., Michaelis, M., Morgenstern, B., & Doerr, H. W. (2005) · International Journal of Molecular Medicine · doi:10.3892/ijmm.15.2.323 · Cited by 34
Global surveillance for severe acute respiratory syndrome (SARS).
(2003) · PubMed · Cited by 29
CARDITIS ASSOCIATED WITH CORONAVIRUS INFECTION
Riski, H., Hovi, T., & Frick, M. H. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92989-x · Cited by 28
Antiseptic properties of two calix[4]arenes derivatives on the human coronavirus 229E
Geller, C., Fontanay, S., Mourer, M., Dibama, H. M., Regnouf‐de‐Vains, J., Finance, C., & Duval, R. E. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2010.09.009 · Cited by 24
Self-citationIshii, K., Hasegawa, H., Nagata, N., Mizutani, T., Morikawa, S., Suzuki, T., Taguchi, F., Tashiro, M., Takemori, T., Miyamura, T., et al. (2006) · Virology · doi:10.1016/j.virol.2006.03.020 · Cited by 21
Geller, C., Fontanay, S., Finance, C., & Duval, R. E. (2009) · Journal of Virological Methods · doi:10.1016/j.jviromet.2009.03.023 · Cited by 17
Self-citation
Cited by
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.
Kampf, G., Todt, D., Pfaender, S., & Steinmann, E. (2020) · Journal of Hospital Infection · doi:10.1016/j.jhin.2020.01.022 · Cited by 3,796
Why does COVID-19 disproportionately affect older people?
Mueller, A. L., McNamara, M. S., & Sinclair, D. A. (2020) · Aging · doi:10.18632/aging.103344 · Cited by 1,128
Eastman, R. T., Roth, J. S., Brimacombe, K. R., Simeonov, A., Shen, M., Patnaik, S., & Hall, M. D. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00489 · Cited by 953
COVID-19: what has been learned and to be learned about the novel coronavirus disease
Yi, Y., Lagniton, P. N. P., Ye, S., Li, E., & Xu, R.-H. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45134 · Cited by 832
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update
Pal, M., Berhanu, G., Desalegn, C., & Kandi, V. (2020) · Cureus · doi:10.7759/cureus.7423 · Cited by 830
Metadata
- Authors
- Geller, C., Varbanov, M., & Duval, R. E.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2012-11-12
- Volume
- 4
- Issue
- 11
- Pages
- 3044-3068
- ISSN
- 1999-4915 (ISSN-L)
- OpenAlex
- W2085499708
- Cited by
- 434
- References
- 119
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.